Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study.
Ghilardi G, Pabst T, Jeker B, Müller R, Cairoli A, Müller AMS, Bargetzi M, Hitz F, Baldomero H, Heim D, Schmidt A, Rossi D, Ghielmini M, Wannesson L, Lerch E, Samaras P, Schanz U, Passweg JR, Stussi G, Kleber M, Gerber B; Swiss Blood Stem Cell Transplantation Registry. Ghilardi G, et al. Among authors: samaras p. Bone Marrow Transplant. 2019 Jul;54(7):1029-1037. doi: 10.1038/s41409-018-0379-y. Epub 2018 Nov 2. Bone Marrow Transplant. 2019. PMID: 30390061 Clinical Trial.
Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastim.
Samaras P, Blickenstorfer M, Siciliano RD, Haile SR, Buset EM, Petrausch U, Mischo A, Honegger H, Schanz U, Stussi G, Stahel RA, Knuth A, Stenner-Liewen F, Renner C. Samaras P, et al. Ann Hematol. 2011 Jan;90(1):89-94. doi: 10.1007/s00277-010-1036-8. Epub 2010 Aug 13. Ann Hematol. 2011. PMID: 20706722
Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience.
Samaras P, Blickenstorfer M, Haile SR, Siciliano RD, Petrausch U, Mischo A, Zweifel M, Honegger H, Schanz U, Stussi G, Taverna C, Bauer S, Knuth A, Stenner-Liewen F, Renner C. Samaras P, et al. Swiss Med Wkly. 2011 May 31;141:w13203. doi: 10.4414/smw.2011.13203. eCollection 2011. Swiss Med Wkly. 2011. PMID: 21630163 Free article.
Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma.
Samaras P, Pfrommer S, Seifert B, Petrausch U, Mischo A, Schmidt A, Schanz U, Nair G, Bargetzi M, Taverna C, Stupp R, Stenner-Liewen F, Renner C. Samaras P, et al. Biol Blood Marrow Transplant. 2015 Jan;21(1):74-80. doi: 10.1016/j.bbmt.2014.09.020. Epub 2014 Sep 30. Biol Blood Marrow Transplant. 2015. PMID: 25278456 Free article.
Efficacious and save use of biosimilar filgrastim for hematopoietic progenitor cell chemo-mobilization with vinorelbine in multiple myeloma patients.
Maul JT, Stenner-Liewen F, Seifert B, Pfrommer S, Petrausch U, Kiessling MK, Schanz U, Nair G, Mischo A, Taverna C, Schmidt A, Bargetzi M, Stupp R, Renner C, Samaras P. Maul JT, et al. Among authors: samaras p. J Clin Apher. 2017 Feb;32(1):21-26. doi: 10.1002/jca.21459. Epub 2016 Mar 22. J Clin Apher. 2017. PMID: 27001243
140 results